Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
Capitol Connections March 1, 2013
Share |

March 1, 2013

IACP Sends Letter to The Washington Post Editor Correcting Story

On February 21, 2013, The Washington Post printed an article, "Pharmacy Trade Group Shifts Position on FDA Oversight."

Please be aware that this article alleging that IACP is now supporting FDA oversight of compounding pharmacy, is neither accurate nor reflective of the complete story.  In fact, IACP gave the reporter very specific written statements which were subsequently given a spin by the journalist.

Click here for the details.

IACP Membership Survey: Input on State and Federal Issues

Policymakers at the state and federal level are addressing the need for new or expanded pharmacy compounding oversight in light of the tragic outcome of New England Compounding Center's (NECC) meningitis outbreak.  IACP has been actively engaged with lawmakers, policy makers and our colleagues at national and state pharmacy associations. As legislative and regulatory language is crafted, IACP has and will continue to provide input on that language to preserve the rights and abilities of pharmacists to engage in compounding of customized medication solutions.

Last week's Member Survey was just one more way the Academy and its Board of Directors needed the input and thoughts of individual practitioners.  While much of the survey focused on the principles for state legislative action adopted last October by the Board, there were many new questions to help IACP formulate policy and recommendations including definitions of "anticipatory compounding," "office-use" compounding, and the differentiation point between manufacturing and compounding.  The more than 200 responses IACP received on those questions will help shape our position and our response to upcoming federal legislation.

"I wanted to gather real people's thoughts," said IACP President Wade Siefert, RPh.  "While our Board represents a broad, diverse, and experienced group of practitioners, the challenges and questions we're hearing from within the profession and from agencies intent on gaining a greater control over pharmacy practice demanded greater input.  I want to thank all of you who participated -- your comments and honest answers will help us address how and where IACP takes its stand to protect our members."

The extensive comments and results are being tabulated and circulated to the IACP Board.  A final summary of the results also will be shared with the IACP membership in our next issue of Capitol Connections.

Member Advisory: Let IACP Know of Drug Shortages

As you all know, we are in an intense period of education and re-education of the public, opinion leaders, and policy makers following the tragic failures at the New England Compounding Center. We are making progress in reinforcing the compounding profession’s commitment to high standards and the best patient care, while also informing the many who are unaware of the crucial role that compounding pharmacists play in the healthcare industry.

You can help us with this. We would request that you keep us informed about how patient access to compounded medications is being affected in the aftermath of this tragedy. There have been troubling and credible reports of shortages of some drugs because of state interpretation and enforcement of regulations.

IACP, of course, supports necessary regulation of the industry to ensure safe drugs and the best patient care. But if in this context you become aware of anything relating to shortages of drugs or inappropriate or unnecessary restrictions on the work that compounding pharmacists do, please call it to our attention in a timely fashion. In this ongoing effort to correct misimpressions about our industry, it is important for us to be aware of the facts. Please help us stay informed about what is going on in your city, state, or region. Forward any relevant information to Dagmar Climo, Director of Communications. Thank you for your help and support.

IACP Encourages CMS to Work with States on USP Compliance

The Centers for Medicare & Medicaid Services (CMS) recently issued an extensive document reviewing various payment aspects and adjustment of rates for carriers. Within that document (click here) is a section on compounding pharmacy claims. Relevant Section on Compounding begins on Page 136.

IACP has submitted a formal recommendation to CMS that it work with the states to require compliance within each state with United States Pharmacopeial Convention (USP) standards. Click here to read IACP's letter to CMS.  

Rahall Introduces H.R.672

U.S. Representative Nick Rahall (D-WV) has introduced H.R.672, which provides for "increased Federal oversight of prescription opioid treatment and assistance to States in reducing opioid abuse, diversion, and deaths."

IACP will continue to monitor this bill as it does all other federal legislation that could impact pharmacists. Click here to review the bill.

Register for USP's Micro Workshop - March 18-19, 2013

The United States Pharmacopeial Convention (USP) is hosting a Micro Workshop on March 18–19, 2013, entitled: “Microbiological Control of Compendial Articles: A Workshop on Current Status and Future Directions of Compendial Standards.” The two-day workshop agenda will feature speakers from USP Expert Committees, FDA staff, as well as from the European and Japanese Pharmacopeias. For more details and to register - please click here

2013 Compounders on Capitol Hill Registration is Open!

The 19th Annual Compounders on Capitol Hill (CCH) will be held June 1-4, 2013, at the Crystal Gateway Marriott in Arlington, Va. Located only two miles from Ronald Reagan National Airport (DCA), the Crystal Gateway Marriott offers immediate lobby access to Washington, D.C.’s world-famous Metro system and a quick ride to all the museums, sights, restaurants, and even the Capitol. Hear from experts during in-depth Continuing Education sessions on legislative and regulatory issues at the state and federal level affecting pharmacy compounding.

Compounders on Capitol Hill

June 1-4, 2013
Crystal Gateway Marriott
1700 Jefferson Davis Highway
Arlington, VA 22202
Reserve your hotel room online by clicking here.
Register to attend the conference before April 2, 2013 and take advantage of advance discount prices.  To register for the conference or for more information, visit

Let the Networking Begin!  Join the CCH Ambassador and First-Timer Program!

As a CCH Ambassador, you will be connected with a first-timer prior to the meeting to share ideas, help to better acquaint them at the meeting, and make introductions. If you would like to be connected with a CCH first-timer at this year's conference, please email Michelle Greene.

Thank you to our CCH Exhibitors and Meeting Sponsors!

We would like to thank the following exhibitors for their commitment to Compounders on Capitol Hill: American College of Apothecaries (ACA); Analytical Research Laboratories (ARL); Associates of Cape Cod, Inc.; B&B Pharmaceuticals, Inc.; bioMérieux; Charles River Laboratory; Digi-Trax Corporation; DYNA Labs; EMD Millipore; Exakt Technologies, Inc.; Freedom Pharmaceuticals, Inc.; International Journal of Pharmaceutical Compounding (IJPC); Letco Medical; Live Oak Bank; MEDISCA; Pharmacy Marketing Quarterly; RXinsider; Storey Marketing; and ZRT Laboratory, LLC.

We would like to thank the following meeting sponsors for their support of Compounders on Capitol Hill: American College of Apothecaries (Continuing Education Provider); B&B Pharmaceuticals (Meeting Tote Bag Sponsor); Fagron (formerly Gallipot) (Meeting Syllabus Sponsor); Freedom Pharmaceuticals, Inc. (Meeting Brochure Sponsor); Letco Medical (Welcome Reception Honoring IACP Fellows Sponsor, IACP AdvanCE Education Session Sponsor); MEDISCA (Meeting T-Shirt Sponsor); PCCA (Name Badge Holder Sponsor, Hotel Room Key Sponsor, Education Session Sponsor); Storey Marketing (Meeting App Sponsor); and Topi-Click Topical Dosing Applicator (Conference Pen Sponsor).  

To learn more about the exhibitors and meeting sponsors, click here.

Boogie Down at IACP Foundation’s 9th Annual Rx Mixer Celebrating Sunday Night Fever


You're invited to a far out fab disco dance with funkadelic good vibes! IACP Foundation's 9th Annual Rx Mixer celebrating Sunday Night Fever which will be held on Sunday, June 2, 2013, at the Crystal Gateway Marriott in Arlington, Va. Last year’s Casablanca-themed event was a blast, and this year we are going DISCO! Disco balls, Lava Lamps, big hair and sparkling accessories – transport yourself back to the glam days of Studio 54. The evening will include cocktails, buffet dinner, live auctions, Treasure Boxes and dancing to our funky music DJ. So break out your dancing shoes and make plans to join us for a fun and outta sight night and help fund the IACP Foundation’s research and education initiatives! Enjoy fellowship with your colleagues from around the country while benefiting the IACP Foundation. Every year, the IACP Foundation hosts a fantastic party with a purpose, the Rx Mixer.  Be sure to purchase your tickets to attend the 9th Annual Rx Mixer as a part of your Compounders on Capitol Hill registration.   

State-by-state Compounding Update

IACP's Compounders Stateside is a one-stop resource for state compounding updates and the latest happenings with the state Boards of Pharmacy. Please be sure to check this page periodically, as it will continue to be updated as situations evolve with each individual state. Click here to view Compounders Stateside which is prominently featured on IACP’s homepage.  

IACP Calendar

IACP is your one-stop resource for all things compounding! CompounderCalendar provides a comprehensive listing of compounding events and continuing education programs.

Click here to view IACP’s Upcoming Events.



 Stay connected to IACP by joining our online communities!


Association Management Software Powered by YourMembership  ::  Legal